The drug development industry had dipped its collective toe into the decentralized trials before COVID-19 disrupted clinical trials. However, the disruption caused by the global pandemic meant that professionals needed to take a deeper dive into DCTs in order to keep research afloat.
Taking clinical studies from a trial site to offsite is more than chancing the geography and scenery. In order to launch a DCT, or make the change from site to patient homes, trial teams need to consider study design, state-of-the-art data collection and management tools, advanced patient engagement technology, and more.
If you’re interested in hearing more about the recipe for DCT success, join us for Outsourcing-Pharma's upcoming webinar on Decentralized Trial Technology. Your registration to this exclusive online event entitles you to listen in on insights shared by a group of leading industry experts:
- Josh Rose, CVS Health Clinical Trial Services
- Walter Stadler, University of Chicago Medicine
- Mohammed Ali, Association of Clinical Research Professionals.
Click here to register today—and feel free to share the sign-up link with colleagues who might benefit from the lively discussion. If you're busy and can't join us at the scheduled date and time, don't worry - your registration enables you to go back and view the webinar at your convenience, as soon as the recording is available.
